Clinical study of the activity and tolerance of hydropropizine, a drug with antitussive activity
Boselli, G.
Minerva Medica 63(51): 2782-2788
1972
ISSN/ISBN: 0026-4806 PMID: 4562221 Document Number: 47282
Document emailed within 1 workday
Related Documents
Castaldi, G. 1975: Study of lactase activity in the development of hepatobiliary drug tolerance Giornale di Clinica Medica 56(5-6): 218-225Kuribara, H.; Tadokoro, S. 1989: Behavioral study on an antitussive and expectorant, and of its constituents. II. Effects on ambulatory activity after repeated administration, and a modification of the methamphetamine sensitivity in mice Arukoru Kenkyu to Yakubutsu Izon 24(5): 430-438
Capretti, G.; Frigerio, G. 1970: Controlled clinical study of the analgesic activity of a new drug (Z. 424) in pain caused by neoplasms La Clinica Terapeutica 52(4): 361-369
Capretti, G.; Frigerio, G. 1970: Controlled clinical study of the analgesic activity of a new drug (Z. 424) in pain caused by neoplasms La Clinica Terapeutica 52(4): 361-369
Strapková, A.; Nosál'ová, G.; Korpás, J. 1987: Relation between the antitussive and analgesic activity of substances Bratislavske Lekarske Listy 88(5): 538-545
Cartwright, K.; Paterson, J.L. 1971: Human volunteer studies of the antitussive activity of dropropizine Journal of Pharmacy and Pharmacology 23: 247s-248s
Sabot, G.; Bagnato, A.; Frigerio, G. 1977: Controlled evaluation of the antitussive activity of viminol p-hydroxybenzoate International Journal of Clinical Pharmacology and Biopharmacy 15(4): 181-183
Vitali, C.; Bencivelli, W.; Isenberg, D.A.; Smolen, J.S.; Snaith, M.L.; Sciuto, M.; Neri, R.; Bombardieri, S. 1992: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE Clinical and Experimental Rheumatology 10(5): 541-547
Olivieri, D.; Giacomelli, P.; Montella, R.; Illiano, A.; Gargano, G.; Pamparana, F. 1983: Clinical study of a new antitussive: cloperastine Archivio Monaldi Per la Tisiologia E le Malattie Dell'apparato Respiratorio 38(5-6): 209-218
Schüetz, E.; Sánchez, J.; García-Barbal, J.; Sarti, J.F.; Reuter, C.; Harrison, F.J. 1991: Therapeutic activity, clinical and gastric tolerance of 20mg daily dose of droxicam in comparison with piroxicam in patients with degenerative joint disease European Journal of Rheumatology and Inflammation 11(4): 21-28
Kikuchi, T.; Tottori, K.; Uwahodo, Y.; Hirose, T.; Miwa, T.; Oshiro, Y.; Morita, S. 1995: 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity Journal of Pharmacology and Experimental Therapeutics 274(1): 329-336
Gordon, M.; Deeks, S.; De Marzo, C.; Goodgame, J.; Guralnik, M.; Lang, W.; Mimura, T.; Pearce, D.; Kaneko, Y. 1997: Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity Journal of Medicine 28(1-2): 108-128
Makarenko, A.N.; Kositsin, N.S.; Nazimov, I.V.; Svinov, M.M.; Goloborod'ko, E.V.; Pasikova, N.V. 2005: A comparative study of antistroke activity of the new drug "cerebral" and its fractions in rats Eksperimental'naia i Klinicheskaia Farmakologiia 68(2): 15-20
Jezzi, B. 1972: Controlled clinical trial of a preparation with steroid activity (prednisone) associated with xylamide, protective drug for the gastric mucosa Minerva Medica 63(67): 3659-3666
Munira, A.; Muheta'er, T.'e.; Resalat, Y.; Xia, N. 2015: Study on composition, antibiotic activity and antioxidant activity of volatile oils from uyghur medicine Althaea rosea Zhongguo Zhong Yao Za Zhi 40(8): 1614-1619
Verhaegen, H. 1982: Activity and tolerance of oxamethacin Methods and Findings in Experimental and Clinical Pharmacology 4(8): 617-623
Sahoo, S.K.; Sahoo, S.K.; Behera, A.; Patil, S.V.; Panda, S.K. 2013: Formulation, in vitro drug release study and anticancer activity of 5-fluorouracil loaded gellan gum microbeads Acta Poloniae Pharmaceutica 70(1): 123-127
Muacević-Kataneca, D.; Bradamante, V.; Reinec, Z.; Sucić, M.; Poljicanin, T.; Busljeta, I.; Metelko, Z. 2005: Clinical study on the effect of simvastatin on butyrylcholinesterase activity Arzneimittel-Forschung 55(5): 271-275
Zou, W.-h.; Qiu, S.-q.; Hong, X.-p.; Wu, Q. 2013: Serum myeloperoxidase activity and serum paraoxonase-1 activity in patients with silicosis and observation subjects and their clinical significance Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 31(1): 58-60
Ol'binskaia, L.I.; Vartanova, O.A.; Aleksandrovskaia, T.N.; Shaldaeva, V.V. 1991: The clinico-biochemical activity and tolerance of the hypolipidemic preparation lipanthyl Terapevticheskii Arkhiv 63(8): 61-64